-transparent.png){kind=logo}
Systemic or topical administration of corticosteroids may produce a rise in intraocular pressure (IOP). Nonsteroidal anti-inflammatory drugs (NSAI drugs) are alternate therapy for ocular inflammatory disease. Flurbiprofen, a new NSAI drug, was tested in double-masked fashion to delineate its effect on IOP. Flurbiprofen did not alter IOP in known high corticosteroid responders nor did it block corticosteroid-induced ocular hypertension.
Related Publications
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
January 1980,
Advances in prostaglandin and thromboxane research,
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
December 2017,
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
June 1991,
Archives of ophthalmology (Chicago, Ill. : 1960),
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
January 1990,
Annals of ophthalmology,
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
August 1986,
Current eye research,
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
June 2005,
American journal of ophthalmology,
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
May 1992,
Archives of ophthalmology (Chicago, Ill. : 1960),
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
April 1973,
Medizinische Monatsschrift,
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
May 1953,
Szemeszet,
D K Gieser, and
E Hodapp, and
I Goldberg, and
M A Kass, and
B Becker
May 1996,
Journal of cataract and refractive surgery,
